These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24238688)

  • 1. Assessment of disease activity, damage and quality of life in systemic lupus erythematosus: new aspects.
    Nuttall A; Isenberg DA
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):309-18. PubMed ID: 24238688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.
    Rizk A; Gheita TA; Nassef S; Abdallah A
    Int J Rheum Dis; 2012 Jun; 15(3):261-7. PubMed ID: 22212605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of systemic lupus erythematosus on oral health-related quality of life.
    Corrêa JD; Branco LGA; Calderaro DC; Mendonça SMS; Travassos DV; Ferreira GA; Teixeira AL; Abreu LG; Silva TA
    Lupus; 2018 Feb; 27(2):283-289. PubMed ID: 28679308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of health related quality of life in systemic lupus erythematosus.
    McElhone K; Abbott J; Teh LS
    Lupus; 2006; 15(10):633-43. PubMed ID: 17120589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
    Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
    Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in children with systemic lupus erythematosus.
    Moorthy LN; Peterson M; Onel KB; Harrison MJ; Lehman TJ
    Curr Rheumatol Rep; 2005 Dec; 7(6):447-52. PubMed ID: 16303104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of life in systemic lupus erythematosus patients, with a particular description of methodology].
    Kulczycka L; Sysa-Jedrzejowska A; Robak E
    Postepy Hig Med Dosw (Online); 2007 Aug; 61():472-7. PubMed ID: 17786134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil.
    Freire EA; Maia IO; Nepomuceno JC; Ciconelli RM
    Clin Rheumatol; 2007 Mar; 26(3):423-8. PubMed ID: 17216369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment.
    Luijten KM; Tekstra J; Bijlsma JW; Bijl M
    Autoimmun Rev; 2012 Mar; 11(5):326-9. PubMed ID: 21958603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subscale analysis of quality of life in patients with systemic lupus erythematosus: association with depression, fatigue, disease activity and damage.
    Choi ST; Kang JI; Park IH; Lee YW; Song JS; Park YB; Lee SK
    Clin Exp Rheumatol; 2012; 30(5):665-72. PubMed ID: 22704691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in systemic lupus erythematosus.
    Panopalis P; Clarke AE
    Clin Dev Immunol; 2006; 13(2-4):321-4. PubMed ID: 17162373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects.
    Yee CS; McElhone K; Teh LS; Gordon C
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):457-67. PubMed ID: 19591777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment measures in systemic lupus erythematosus.
    Freire EA; Souto LM; Ciconelli RM
    Rev Bras Reumatol; 2011; 51(1):70-80. PubMed ID: 21412607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus.
    Piga M; Congia M; Gabba A; Figus F; Floris A; Mathieu A; Cauli A
    Lupus; 2018 Feb; 27(2):190-198. PubMed ID: 28618891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-specific quality of life in patients with lupus nephritis.
    Jolly M; Toloza S; Goker B; Clarke AE; Navarra SV; Wallace D; Weisman M; Mok CC
    Lupus; 2018 Feb; 27(2):257-264. PubMed ID: 28728507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving measures of disease activity in systemic lupus erythematosus.
    Banjari M; Touma Z; Gladman DD
    Expert Rev Clin Immunol; 2023 Feb; 19(2):193-202. PubMed ID: 36503376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.